Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER Trial)

American Journal of Cardiology

Volumn 96, Issue 9, 2005, Pages 1207-1213

  Dupuis, Jocelyn ^a   Tardif, Jean Claude ^a   Rouleau, Jean Lucien ^a   Ricci, Joseph ^b   Arnold, Malcolm ^c   Lonn, Eva ^d   Roux, Rená ^e   Title, Lawrence M ^f   Amyot, Robert ^g   Bonafede, Nickie ^h   Woo, Anna ⁱ   Cannon, Christopher P ^j  

^a MONTREAL HEART INSTITUTE   (Canada)

^b Scarborough Cardiology Research   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e Bureau des Internistes de Drummondville   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^h Brampton Engineering Inc   (Canada)

ⁱ TORONTO GENERAL HOSPITAL   (Canada)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; C REACTIVE PROTEIN; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL TRIAL; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; VASODILATATION;

ACUTE DISEASE; ANTICHOLESTEREMIC AGENTS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CHOLESTEROL, LDL; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PRAVASTATIN; PROGNOSIS; PYRROLES; SYNDROME; VASODILATION;

EID: 27144522539     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.057     Document Type: Article

References (16)

1. J. Dupuis, J.C. Tardif, P. Cernacek, P. Theroux Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial Circulation 99 1999 3227 3233
2. J.N. Cohn, A.A. Quyyumi, N.K. Hollenberg, K.A. Jamerson Surrogate markers for cardiovascular disease functional markers Circulation 109 2004 IV31 IV46
3. J.A. Vita, J.F. Keaney Jr Hormone replacement therapy and endothelial function the exception that proves the rule? Arterioscler Thromb Vasc Biol 21 2001 1867 1869
4. T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, E.H. Lieberman, P. Ganz, M.A. Creager, A.C. Yeung Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 1995 1235 1241
5. M. Hashimoto, H. Akita Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days Circulation 105 2002 E30 E31
6. H. Omori, H. Nagashima, Y. Tsurumi, A. Takagi, N. Ishizuka, N. Hagiwara, M. Kawana, H. Kasanuki Direct in vivo evidence of a vascular statin a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects Br J Clin Pharmacol 54 2002 395 399
7. K. Sakabe, N. Fukuda, K. Wakayama, T. Nada, H. Shinohara, Y. Tamura Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients Int J Cardiol 94 2004 111 117
8. G. O'Driscoll, D. Green, R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131
9. C.B. Treasure, J.L. Klein, W.S. Weintraub, J.D. Talley, M.E. Stillabower, A.S. Kosinski, J. Zhang, S.J. Boccuzzi, J.C. Cedarholm, R.W. Alexander Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487
10. T. Neunteufl, K. Kostner, R. Katzenschlager, M. Zehetgruber, G. Maurer, F. Weidinger Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men J Am Coll Cardiol 32 1998 711 716
11. U. Laufs, V. La Fata, J. Plutzky, K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
12. J. Davignon, R.F. Jacob, R.P. Mason The antioxidant effects of statins Coron Artery Dis 15 2004 251 258
13. C. Guijarro, L.M. Blanco-Colio, M. Ortego, C. Alonso, A. Ortiz, J.J. Plaza, C. Diaz, G. Hernandez, J. Egido 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture Circ Res 83 1998 490 500
14. N. Gruhn, S. Boesgaard, J. Eiberg, L. Bang, J. Thiis, T.V. Schroeder, J. Aldershvile Effects of large conductance Ca(2+)-activated K(+) channels on nitroglycerin-mediated vasorelaxation in humans Eur J Pharmacol 446 2002 145 150
15. A.L. Kleschyov, M. Oelze, A. Daiber, Y. Huang, H. Mollnau, E. Schulz, K. Sydow, B. Fichtlscherer, A. Mulsch, T. Munzel Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res 93 2003 E104 E112
16. J.A. Beckman, J.K. Liao, S. Hurley, L.A. Garrett, D. Chui, D. Mitra, M.A. Creager Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein Circ Res 95 2004 217 223